Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.60)
# 854
Out of 4,913 analysts
503
Total ratings
41.62%
Success rate
8.53%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLSD Clearside Biomedical | Downgrades: Neutral | $5 | $0.45 | +1,023.34% | 22 | Jul 18, 2025 | |
| ANGO AngioDynamics | Reiterates: Buy | $16 | $9.12 | +75.44% | 11 | Jul 16, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $100 | $61.98 | +61.34% | 20 | Jul 3, 2025 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $7 → $5 | $0.90 | +458.66% | 6 | Jul 1, 2025 | |
| ZYXI Zynex | Reiterates: Buy | $8 | $2.55 | +213.73% | 23 | Jun 30, 2025 | |
| LPCN Lipocine | Reiterates: Buy | $8 | $3.40 | +135.45% | 3 | Jun 27, 2025 | |
| EDSA Edesa Biotech | Assumes: Buy | $5 | $2.33 | +114.59% | 1 | Jun 27, 2025 | |
| ELDN Eledon Pharmaceuticals | Assumes: Buy | $9 | $3.23 | +178.64% | 1 | Jun 18, 2025 | |
| EYPT EyePoint Pharmaceuticals | Reiterates: Buy | $22 | $10.04 | +119.12% | 22 | May 29, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $15 | $12.08 | +24.17% | 27 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.03 | +142.72% | 21 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $8.73 | +106.19% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $12 | $7.93 | +51.32% | 22 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.61 | +148.45% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $53 | $25.03 | +111.75% | 4 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $22.23 | +34.98% | 2 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $60 | $34.86 | +72.12% | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $12.79 | +95.47% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.73 | +156.42% | 13 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $22.61 | +121.14% | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $14.44 | +3.88% | 18 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $10.87 | +28.79% | 9 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.00 | +200.00% | 18 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $11.55 | +237.66% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $32 | $17.90 | +78.77% | 14 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.73 | +242.33% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.27 | +205.81% | 1 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.35 | +122.22% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $5.35 | +124.30% | 19 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $3.41 | +252.42% | 4 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.95 | +214.83% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.28 | +260.62% | 23 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.93 | +241.30% | 16 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.29 | +112.77% | 19 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.55 | +93.55% | 13 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $8.79 | +286.80% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.53 | +471.43% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.96 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5,250 → $1,125 | $4.99 | +22,445.09% | 18 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.26 | +3,710.98% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.44 | +2,377.48% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.75 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $16.07 | +198.69% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $36.79 | -48.36% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.38 | - | 2 | Apr 16, 2020 |
Clearside Biomedical
Jul 18, 2025
Downgrades: Neutral
Price Target: $5
Current: $0.45
Upside: +1,023.34%
AngioDynamics
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $9.12
Upside: +75.44%
Belite Bio
Jul 3, 2025
Reiterates: Buy
Price Target: $100
Current: $61.98
Upside: +61.34%
Lexaria Bioscience
Jul 1, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $0.90
Upside: +458.66%
Zynex
Jun 30, 2025
Reiterates: Buy
Price Target: $8
Current: $2.55
Upside: +213.73%
Lipocine
Jun 27, 2025
Reiterates: Buy
Price Target: $8
Current: $3.40
Upside: +135.45%
Edesa Biotech
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $2.33
Upside: +114.59%
Eledon Pharmaceuticals
Jun 18, 2025
Assumes: Buy
Price Target: $9
Current: $3.23
Upside: +178.64%
EyePoint Pharmaceuticals
May 29, 2025
Reiterates: Buy
Price Target: $22
Current: $10.04
Upside: +119.12%
Ocular Therapeutix
May 29, 2025
Reiterates: Buy
Price Target: $15
Current: $12.08
Upside: +24.17%
May 29, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.03
Upside: +142.72%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $8.73
Upside: +106.19%
May 23, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $7.93
Upside: +51.32%
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.61
Upside: +148.45%
May 15, 2025
Maintains: Buy
Price Target: $51 → $53
Current: $25.03
Upside: +111.75%
May 13, 2025
Reiterates: Buy
Price Target: $30
Current: $22.23
Upside: +34.98%
May 12, 2025
Maintains: Buy
Price Target: $57 → $60
Current: $34.86
Upside: +72.12%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $12.79
Upside: +95.47%
May 5, 2025
Reiterates: Buy
Price Target: $7
Current: $2.73
Upside: +156.42%
May 5, 2025
Reiterates: Buy
Price Target: $50
Current: $22.61
Upside: +121.14%
May 2, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $14.44
Upside: +3.88%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $10.87
Upside: +28.79%
Apr 29, 2025
Reiterates: Buy
Price Target: $9
Current: $3.00
Upside: +200.00%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $11.55
Upside: +237.66%
Apr 17, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $17.90
Upside: +78.77%
Apr 11, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.73
Upside: +242.33%
Apr 9, 2025
Initiates: Buy
Price Target: $10
Current: $3.27
Upside: +205.81%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.35
Upside: +122.22%
Apr 4, 2025
Reiterates: Buy
Price Target: $12
Current: $5.35
Upside: +124.30%
Apr 4, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $3.41
Upside: +252.42%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.95
Upside: +214.83%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.28
Upside: +260.62%
Mar 28, 2025
Reiterates: Buy
Price Target: $10
Current: $2.93
Upside: +241.30%
Mar 25, 2025
Reiterates: Buy
Price Target: $7
Current: $3.29
Upside: +112.77%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $1.55
Upside: +93.55%
Mar 21, 2025
Reiterates: Buy
Price Target: $34
Current: $8.79
Upside: +286.80%
Jan 2, 2025
Reiterates: Buy
Price Target: $3
Current: $0.53
Upside: +471.43%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.96
Upside: -
Jun 10, 2024
Maintains: Buy
Price Target: $5,250 → $1,125
Current: $4.99
Upside: +22,445.09%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.26
Upside: +3,710.98%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.44
Upside: +2,377.48%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.75
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $16.07
Upside: +198.69%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $36.79
Upside: -48.36%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.38
Upside: -